Guo JiaGang
National Institute of Parasitic Diseases
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Guo JiaGang.
Bulletin of The World Health Organization | 2005
Chen Xianyi; Wang Liying; Cai Jiming; Zhou Xiao-Nong; Zheng Jiang; Guo JiaGang; Wu XiaoHua; Dirk Engels; Chen Minggang
China has been carrying out large-scale schistosomiasis control since the mid-1950s, but in the early 1990s, schistosomiasis was still endemic in eight provinces. A World Bank Loan Project enabled further significant progress to be made during the period 1992-2001. The control strategy was focused on the large-scale use of chemotherapy -- primarily to reinforce morbidity control -- while at the same time acting on transmission with the ultimate goal of interrupting it. Chemotherapy was complemented by health education, chemical control of snails and environmental modification where appropriate. A final evaluation in 2002 showed that infection rates in humans and livestock had decreased by 55% and 50%, respectively. The number of acute infections and of individuals with advanced disease had also significantly decreased. Although snail infection rates continued to fluctuate at a low level, the densities of infected snails had decreased by more than 75% in all endemic areas. The original objectives of the China World Bank Loan Project for schistosomiasis control had all been met. One province, Zhejiang, had already fulfilled the criteria for elimination of schistosomiasis by 1995. The project was therefore a success and has provided China with a sound basis for further control.
Acta Tropica | 2002
Jiang Qing-wu; Wang Liying; Guo JiaGang; Chen Minggang; Zhou XiaoNong; Dirk Engels
After reviewing the schistosomiasis control program in China with focusing on the socio-economic impact on schistosomiasis endemicity, we introduce the promotion process of morbidity control strategy undertaken before and during the World Bank Loan Project (WBLP) on Schistosomiasis Control. We analyzed the data derived from case study of morbidity control for schistosomiasis, and evaluated the efficacy of chemotherapy. It is suggested that appropriate drug treatment declines worm burden and the intensity of infection as well as prevalence, but chemotherapy alone can hardly reduce the transmission because zoonotic Schistosoma japonicum infection has a great impact on the transmission of the disease. Therefore, the strategies in different (high, medium, and low) transmission areas during the maintenance stage were put forward in consideration of challenges in national control program in the future.
Parasitology International | 2000
Hongchang Yuan; Guo JiaGang; Robert Bergquist; Marcel Tanner; Chen Xianyi; Wang Huanzeng
Ongoing efforts over the last 50 years, aiming at the elimination of schistosomiasis in the Peoples Republic of China, have been spectaculary successful in reducing the prevalence and intensity of the infection. The endemic areas have been reduced to core regions with particular problems such as the middle and lower reaches of the Changjiang River (Yangtze), the land adjacent to the lakes of central China and certain mountainous areas in Sichuan and Yunnan. An effort to eradicate schistosomiasis as a public health problem in these areas, by means of mass chemotherapy in regions of high prevalence and selective chemotherapy in others, provided good results initially but a lasting effect proved unattainable with chemotherapy alone. A small part of the funds available for this effort were used for research and training. Overseen by a Joint Research Management Committee (JRMC), research training was intensified resulting in improved applications and a better quality of the scientific level of the research finally carried out. Several new control tools were produced which may improve future control approaches, which might achieve a more than temporary relief. In evaluating the contributions made, it was found that the great environmental variations between the eight provinces where control activities were implemented was the main reason why general use of chemotherapy only could not be entirely successful. The inclusion of a research component proved beneficial both for the short- and long-term control and the JRMC proved useful in exposing that sustained progress cannot be achieved without back-up by other approaches, e.g. snail control. Suggested future activities include strengthening of intersectoral and industrial collaboration but finding financial support for continuing the JRMC initiative in some form. It is crucial to consolidate progress made.
Chinese journal of schistosomiasis control | 2012
Hao Yang; Zheng Hao; Zhu Rong; Guo JiaGang; Wang Liying; Chen Zhao; Zhou XiaoNong
Chinese Medical Journal | 2009
Li ShiZhu; A. Luz; Wang XianHong; Xu LiLi; Wang Qiang; Qian YingJun; Wu XiaoHua; Guo JiaGang; Xia Gang; Wang Liying; Zhou XiaoNong
Chinese journal of schistosomiasis control | 2009
Hao Yang; Zheng Hao; Zhu Rong; Guo JiaGang; Wu XiaoHua; Wang Liying; Chen Zhao; Zhou XiaoNong
Chinese journal of schistosomiasis control | 2009
Zhu Kong; Dang Hui; Zhang Lijuan; Li HuaZhong; Zheng CanJun; Wu XiaoHua; Guo JiaGang
Chinese journal of schistosomiasis control | 2009
Chen HongGen; Zeng XiaoJun; Xiong JiJie; Jiang WeiSheng; Hong XianLin; Hu ShenZhu; Guo JiaGang
Chinese journal of schistosomiasis control | 2009
Hao Yang; Yi DongHua; Zhang XianFeng; Xiong JiJie; Yuan WenZong; Hu ShouJing; Wu XiaoHua; Zhu Rong; Guo JiaGang; Huang XiBao; Li YueSheng; Chen HongGen; Wang TianPing; Dong XingQi; Li HuaZhong; Zheng CanJun; Chen Zhao; Wang Liying; Zhou XiaoNong
Chinese journal of schistosomiasis control | 2010
Cao Chunli; Guo JiaGang